Literature DB >> 18793688

Anxiolytic-like effect of neuropeptide S in the rat defensive burying.

Giovanni Vitale1, Monica Filaferro, Valentina Ruggieri, Sonia Pennella, Claudio Frigeri, Anna Rizzi, Remo Guerrini, Girolamo Calò.   

Abstract

Neuropeptide S (NPS) has been recently identified as the endogenous ligand of a previously orphan G-protein-coupled receptor now named NPSR. Both NPS and its receptor are expressed in the brain, where they modulate different functions. In particular, it has been demonstrated that intracerebroventricular (i.c.v.) injection of NPS in rodents increases wakefulness and promotes anxiolytic-like effects. In the present study we used the defensive burying (DB) test in rats to further investigate the action of human NPS (0.1-10 nmol, i.c.v.) on anxiety-related behaviors. Diazepam (1.5mg/kg, i.p.) and caffeine (20mg/kg, i.p.) were used in parallel experiments as standard anxiolytic and anxiogenic drugs, respectively. None of the tested drugs produced statistical differences in the latency to contact the probe, burying behavior latency, number of shocks received or immobility/freezing duration. Caffeine increased cumulative burying behavior and the buried bedding height in a statistically significant manner thus promoting anxiogenic like effects. Opposite results were obtained with diazepam that significantly reduced these behavioral parameters. The anxiolytic-like action of diazepam was mimicked by NPS that reduced cumulative burying behavior in a dose dependent manner. Collectively, robust anxiolytic-like effects were recorded in response to NPS in the DB test. These results are of particular interest since the outcome of this assay is marginally influenced by drug effects on locomotor activity. In conclusion, we provide further evidence that NPS evokes genuine anxiolytic-like effects in the rat; therefore NPSR selective agonists are worthy of development as innovative drugs for the treatment of anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793688     DOI: 10.1016/j.peptides.2008.08.014

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  27 in total

1.  Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.

Authors:  Stewart D Clark; Terrence P Kenakin; Steven Gertz; Carla Hassler; Elaine A Gay; Tiffany L Langston; Rainer K Reinscheid; Scott P Runyon
Journal:  Neuropharmacology       Date:  2017-03-03       Impact factor: 5.250

2.  Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1.

Authors:  Hongyan Zhu; Melissa K Mingler; Melissa L McBride; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Michael T Williams; Charles V Vorhees; Marc E Rothenberg
Journal:  Psychoneuroendocrinology       Date:  2010-02-19       Impact factor: 4.905

3.  Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor.

Authors:  Kay Jüngling; Xiaobin Liu; Jörg Lesting; Philippe Coulon; L Sosulina; Rainer K Reinscheid; Hans-Christian Pape
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

4.  Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice.

Authors:  Carina R Boeck; Caroline Martinello; Adalberto A de Castro; Morgana Moretti; Tiago Dos Santos Casagrande; Remo Guerrini; Girolamo Calo'; Elaine C Gavioli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-19       Impact factor: 3.000

5.  Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala.

Authors:  Thomas Grund; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2017-08-14       Impact factor: 7.853

6.  Neuropeptide S receptor gene variation and neural correlates of cognitive emotion regulation.

Authors:  Anne Guhn; Katharina Domschke; Laura D Müller; Thomas Dresler; Florian Eff; Juliane Kopf; Jürgen Deckert; Andreas Reif; Martin J Herrmann
Journal:  Soc Cogn Affect Neurosci       Date:  2015-05-13       Impact factor: 3.436

7.  Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation.

Authors:  Carla Hassler; Yanan Zhang; Brian Gilmour; Tyler Graf; Timothy Fennell; Rodney Snyder; Jeffrey R Deschamps; Rainer K Reinscheid; Celia Garau; Scott P Runyon
Journal:  ACS Chem Neurosci       Date:  2014-07-11       Impact factor: 4.418

8.  Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation.

Authors:  Katharina Domschke; Benedikt Klauke; Bernward Winter; Agnes Gajewska; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Andrea Dlugos; Swantje Naunin; Kathrin Nienhaus; Manfred Fobker; Christian Jacob; Volker Arolt; Paul Pauli; Andreas Reif; Peter Zwanzger; Jürgen Deckert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-08       Impact factor: 4.530

9.  Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat.

Authors:  Marsida Kallupi; Giordano de Guglielmo; Nazzareno Cannella; Hong Wu Li; Girolamo Caló; Remo Guerrini; Massimo Ubaldi; John J Renger; Victor N Uebele; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2012-11-13       Impact factor: 4.530

Review 10.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.